| ²é¿´: 679 | »Ø¸´: 3 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
zlp-lwľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¼±£¡£¡£¡ËµÃ÷Õâ¸ö¹«Ê½ÖеÄXiºÍx¾ßÌåÊÇÄǸö¾ØÕó
|
|
|
the chemical domain of the model was described by leverage (h) approach , defined as: ¹«Ê½¼û¸½¼þ£º where xi is the descriptor row vector of the query drug molecule, X is the n k 1 matrix of k model descriptor values for n training set drugs. The superscript ¡®¡®T¡¯¡¯ refers to the transpose of the matrix/vector |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ¸½¼þ.doc
2013-01-22 11:21:52, 16 K
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ3È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼ÓÖдÓʼþÁË£¬Ã»»Ø¸´
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧ˶318Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700»¯¹¤Ñ§Ë¶µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Hermite¾ØÕóµÄÌØÕ÷Öµ¼ÆËãÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾ÌÖÂÛ¡¿Ô¤µ÷¼þ¹²éîÌݶȷ¨£¨PCG£©
ÒѾÓÐ50È˻ظ´
zlp-lw
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 2547.1
- É¢½ð: 85
- ºì»¨: 6
- Ìû×Ó: 451
- ÔÚÏß: 324.1Сʱ
- ³æºÅ: 1502426
- ×¢²á: 2011-11-21
- רҵ: Ì¼ËØ²ÄÁÏÓ볬Ӳ²ÄÁÏ
3Â¥2013-01-24 09:07:31
myIDname
ľ³æ (ÖøÃûдÊÖ)
ÈËÃñ´ó»áÌÃÊ×ϯÇå½à¹¤
- SFL-EPI: 17
- Ó¦Öú: 143 (¸ßÖÐÉú)
- ¹ó±ö: 0.295
- ½ð±Ò: 1700.4
- É¢½ð: 1020
- ºì»¨: 30
- ɳ·¢: 2
- Ìû×Ó: 2540
- ÔÚÏß: 414.7Сʱ
- ³æºÅ: 1586017
- ×¢²á: 2012-01-24
- רҵ: ΢/ÄÉ»úеϵͳ

2Â¥2013-01-23 10:06:49
zlp-lw
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 2547.1
- É¢½ð: 85
- ºì»¨: 6
- Ìû×Ó: 451
- ÔÚÏß: 324.1Сʱ
- ³æºÅ: 1502426
- ×¢²á: 2011-11-21
- רҵ: Ì¼ËØ²ÄÁÏÓ볬Ӳ²ÄÁÏ
4Â¥2013-01-24 09:10:11













»Ø¸´´ËÂ¥
ËÍÏÊ»¨Ò»¶ä